SURVYR

DVA

DaVita Inc.
$181.69
−$2.34 (1.27%)Oct 27 close
Health CareS&P 500 CompareTechnicals
1M3M6M1Y2Y
-22%+6%+35%+63%+91%Oct 2025Oct 2026Apr 202652w high $247.4952w low $101.00
DVASPY
Wall St. Highest PT $270.00 (+48.6%) Wall St. Avg PT $219.86 (+21.0%)
$104$147$191$235$278POC $148Hi $270Avg $220
Underwater Drawdown %Max DD -27.9%Current -24.6%
0.0%-27.9%
Relative Strength vs SPY+26.7% vs SPYOutperforming
+90%0%-90%
1W
+$6.34 (3.62%)
1M
+$3.22 (1.80%)
3M
−$57.77 (24.13%)
6M
+$31.62 (21.07%)
YTD
+$68.08 (59.92%)
1Y
+$52.14 (40.25%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street analyst consensus
SellHoldStrong Buy
Buy
7 analysts · mean score 2.38
1 = Strong Buy · 5 = Sell
Wall Street consensus
Analyst price targets
Current price$181.69
Average target$219.86
+$38.17 (+21.0%) upsideaverage target vs current price
CurrentAverageMedian
Low$165.00
Median$219.86
High$270.00
12-month Wall Street target range

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$11.2B
P/E (last 12 months)14.8
P/E (next 12 months, estimated)10.2
52-week range$101.00 – $247.49
Revenue growth (latest quarter vs a year ago)+5.2%
Dividend yieldNo dividend
Analyst consensusBuy (7)
Average analyst price target$219.86 (+21%)

What they do

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services.

Healthcare · Medical Care Facilities
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

Momentum
76th percentile in sector
B+
12-1 return: +47.0%
Percentile within its GICS sector across the S&P 1500.
Growth
28th percentile in sector
D+
Revenue growth (YoY): +5.2%
Percentile within its GICS sector across the S&P 1500.
Value
83rd percentile in sector
A-
Forward E/P: 9.2% · EBITDA/EV: 10.7%
Percentile within its GICS sector across the S&P 1500.
Profitability
70th percentile in sector
B
Profit margin: +6.0% · Return on equity: +88.5%
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
ranked 129 of 499 · 12-month momentum 32.5%
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

DVA earningsReports tomorrow
Next report · quarter Sep 2026
Thu Oct 29, 2026After the close
EPS consensus$3.57
Revenue consensus–
Last 4 quarters · EPS vs estimate
Aug 4, 2026$4.02est $3.88+3.5%Above estimates
May 5, 2026$2.87est $2.33+23.2%Above estimates
Feb 2, 2026$3.40est $3.19+6.5%Above estimates
Oct 29, 2025$2.51est $3.17−20.9%Below estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · report time: Nasdaq earnings calendar · refreshed 2026-10-27 17:51:09 ET
24-1025-0225-0525-0825-1026-0226-0526-080.004.02
EstimateActual (beat)Actual (miss)

News & catalysts

More news
DaVita earnings: what to look for from DVA
StockStory · 5h ago
Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends?
Zacks · 22h ago
DaVita Brings Preventive Health Screenings Into Communities to Help Identify Hidden Health Risks
PR Newswire · Oct 27
ALLIANCEBERNSTEIN GLOBAL HIGH INCOME FUND, INC. RELEASES MONTHLY PORTFOLIO UPDATE
PR Newswire · Oct 26
1 of Wall Street’s favorite stocks worth investigating and 2 we find risky
StockStory · Oct 26
Insider trades
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–

Stats refreshed 2026-10-27 17:51:09 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026